BioXcel Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2017 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
BioXcel Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2017 to Q2 2024.
  • BioXcel Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 40.4M shares, a 38% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 40.4M +11.1M +38% Jun 30, 2024 10-Q 2024-08-06
Q1 2024 33.6M +4.53M +15.6% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 29.9M +1.78M +6.34% Dec 31, 2023 10-Q 2024-08-06
Q3 2023 29.3M +1.25M +4.46% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 29.3M +1.25M +4.46% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 29.1M +1.12M +4% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 28.1M +167K +0.6% Dec 31, 2022 10-K 2024-03-22
Q3 2022 28M +43K +0.15% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 28M +49K +0.18% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 28M +3.35M +13.6% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 28M +3.56M +14.6% Dec 31, 2021 10-K 2023-03-16
Q3 2021 28M +3.63M +14.9% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 28M +7.62M +37.4% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 24.6M +4.45M +22% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 24.4M +6.33M +35% Dec 31, 2020 10-K 2022-03-11
Q3 2020 24.4M +6.32M +35% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 20.4M +4.67M +29.7% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 20.2M +4.52M +28.8% Mar 31, 2020 10-Q 2020-05-12
Q4 2019 18.1M +2.42M +15.5% Dec 31, 2019 10-K 2021-03-12
Q3 2019 18M +2.39M +15.3% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 15.7M +42K +0.27% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 15.7M +20.3K +0.13% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 15.7M +5.76M +58.1% Dec 31, 2018 10-K 2020-03-09
Q3 2018 15.6M Sep 30, 2018 10-Q 2018-11-09
Q2 2018 15.6M Jun 30, 2018 10-Q 2018-08-08
Q1 2018 15.6M Mar 31, 2018 10-Q 2018-05-14
Q4 2017 9.91M Dec 31, 2017 10-K 2019-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.